Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients

By sjmartinez • January 17, 2023

Schaenman J, Rossetti M, Pickering H, Sunga G, Wilhalme H, Elashoff D, Zhang Q, Hickey M, Reddy U, Danovitch G, Reed EF, Bunnapradist S. Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients. Kidney Int Rep. 2022 Oct 20;8(1):126-140. doi: 10.1016/j.ekir.2022.10.015. PMID: 36644348; PMCID: PMC9832066.

Tags: belatacept, CMV, immunosuppression, Infectious Diseases, Publications, T cell, transplantation

Related Posts

Field evaluation of a dual treponemal/non-treponemal point-of-care test for syphilis within an HIV pre-exposure prophylaxis programme in Hanoi, Vietnam

Biba U, Bui HTM, Nguyen LT, Dang HT, Bui TT, Nguyen TC, Dau NS, Pham LQ, Giang LM, Adamson PC. Field evaluation of a dual[...]

Correction: Empowering Women’s PrEP Choices: Qualitative Insights into Long-Acting PrEP Preferences and Decision-Making during Pregnancy and Breastfeeding in South Africa and Botswana

Chen-Charles J, De Vos L, Vundhla P, Gebengu A, Rousseau E, Bekker LG, Peters R, Mussa A, Morroni C, Toska E, Babalola CM, Klausner JD,[...]

Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

Costa Monteiro AC, Pickering H, Sarma A, Taylor CS, Jenkins MM, Hsu FM, Nadel B, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA,[...]